These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 27372421)
1. In situ diselenide-crosslinked polymeric micelles for ROS-mediated anticancer drug delivery. Deepagan VG; Kwon S; You DG; Nguyen VQ; Um W; Ko H; Lee H; Jo DG; Kang YM; Park JH Biomaterials; 2016 Oct; 103():56-66. PubMed ID: 27372421 [TBL] [Abstract][Full Text] [Related]
2. Photosensitizer enhanced disassembly of amphiphilic micelle for ROS-response targeted tumor therapy in vivo. Dai L; Yu Y; Luo Z; Li M; Chen W; Shen X; Chen F; Sun Q; Zhang Q; Gu H; Cai K Biomaterials; 2016 Oct; 104():1-17. PubMed ID: 27423095 [TBL] [Abstract][Full Text] [Related]
3. Visible-Light-Induced Diselenide-Crosslinked Polymeric Micelles for ROS-Triggered Drug Delivery. Cheng X; Li H; Sun X; Xu T; Guo Z; Du X; Li S; Li X; Xing X; Qiu D Molecules; 2024 Aug; 29(16):. PubMed ID: 39203048 [TBL] [Abstract][Full Text] [Related]
4. Effect of hydrophobicity of core on the anticancer efficiency of micelles as drug delivery carriers. Sun CY; Ma YC; Cao ZY; Li DD; Fan F; Wang JX; Tao W; Yang XZ ACS Appl Mater Interfaces; 2014 Dec; 6(24):22709-18. PubMed ID: 25426800 [TBL] [Abstract][Full Text] [Related]
5. Interface crosslinked mPEG-b-PAGE-b-PCL triblock copolymer micelles with high stability for anticancer drug delivery. Lu Y; Gao X; Cao M; Wu B; Su L; Chen P; Miao J; Wang S; Xia R; Qian J Colloids Surf B Biointerfaces; 2020 May; 189():110830. PubMed ID: 32045844 [TBL] [Abstract][Full Text] [Related]
6. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles. Fang Y; Jiang Y; Zou Y; Meng F; Zhang J; Deng C; Sun H; Zhong Z Acta Biomater; 2017 Mar; 50():396-406. PubMed ID: 28065871 [TBL] [Abstract][Full Text] [Related]
7. Visible light-induced crosslinking and physiological stabilization of diselenide-rich nanoparticles for redox-responsive drug release and combination chemotherapy. Zhai S; Hu X; Hu Y; Wu B; Xing D Biomaterials; 2017 Mar; 121():41-54. PubMed ID: 28068593 [TBL] [Abstract][Full Text] [Related]
8. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy. Ruttala HB; Chitrapriya N; Kaliraj K; Ramasamy T; Shin WH; Jeong JH; Kim JR; Ku SK; Choi HG; Yong CS; Kim JO Acta Biomater; 2017 Nov; 63():135-149. PubMed ID: 28890258 [TBL] [Abstract][Full Text] [Related]
9. Facile construction of dual-bioresponsive biodegradable micelles with superior extracellular stability and activated intracellular drug release. Chen W; Meng F; Cheng R; Deng C; Feijen J; Zhong Z J Control Release; 2015 Jul; 210():125-33. PubMed ID: 25987525 [TBL] [Abstract][Full Text] [Related]
10. Self-Assembled Monomethoxy (Polyethylene Glycol)-b-P(D,L-Lactic-co-Glycolic Acid)-b-P(L-Glutamic Acid) Hybrid-Core Nanoparticles for Intracellular pH-Triggered Release of Doxorubicin. Xu H; Cai C; Gou J; Sui B; Jin J; Xu H; Zhang Y; Wang L; Zhai Y; Tang X J Biomed Nanotechnol; 2015 Aug; 11(8):1354-69. PubMed ID: 26295138 [TBL] [Abstract][Full Text] [Related]
11. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. Talelli M; Iman M; Varkouhi AK; Rijcken CJ; Schiffelers RM; Etrych T; Ulbrich K; van Nostrum CF; Lammers T; Storm G; Hennink WE Biomaterials; 2010 Oct; 31(30):7797-804. PubMed ID: 20673684 [TBL] [Abstract][Full Text] [Related]
12. Intracellular release of doxorubicin from core-crosslinked polypeptide micelles triggered by both pH and reduction conditions. Wu L; Zou Y; Deng C; Cheng R; Meng F; Zhong Z Biomaterials; 2013 Jul; 34(21):5262-72. PubMed ID: 23570719 [TBL] [Abstract][Full Text] [Related]
13. Mesoscopic simulations of drug-loaded diselenide crosslinked micelles: Stability, drug loading and release properties. Lin W; Xue Z; Wen L; Li Y; Liang Z; Xu J; Yang C; Gu Y; Zhang J; Zu X; Luo H; Yi G; Zhang L Colloids Surf B Biointerfaces; 2019 Oct; 182():110313. PubMed ID: 31306830 [TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-poly (ethylene glycol)-alendronate self-assembled micelles for targeted therapy of bone metastatic cancer. Ye WL; Zhao YP; Li HQ; Na R; Li F; Mei QB; Zhao MG; Zhou SY Sci Rep; 2015 Sep; 5():14614. PubMed ID: 26419507 [TBL] [Abstract][Full Text] [Related]
15. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy. Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942 [TBL] [Abstract][Full Text] [Related]
16. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect. Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017 [TBL] [Abstract][Full Text] [Related]
17. pH triggered doxorubicin delivery of PEGylated glycolipid conjugate micelles for tumor targeting therapy. Hu FQ; Zhang YY; You J; Yuan H; Du YZ Mol Pharm; 2012 Sep; 9(9):2469-78. PubMed ID: 22827551 [TBL] [Abstract][Full Text] [Related]
18. Reduction/temperature/pH multi-stimuli responsive core cross-linked polypeptide hybrid micelles for triggered and intracellular drug release. Qu J; Wang QY; Chen KL; Luo JB; Zhou QH; Lin J Colloids Surf B Biointerfaces; 2018 Oct; 170():373-381. PubMed ID: 29940504 [TBL] [Abstract][Full Text] [Related]
19. pH-responsive unimolecular micelle-gold nanoparticles-drug nanohybrid system for cancer theranostics. Lin W; Yao N; Qian L; Zhang X; Chen Q; Wang J; Zhang L Acta Biomater; 2017 Aug; 58():455-465. PubMed ID: 28583900 [TBL] [Abstract][Full Text] [Related]